
Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd. (CMMB)
WebsitePrice
Market cap
Next catalystRA Phase 2 recruitment expected in H1 2027, subject to FDA IND acceptance and the post-merger combined-company planNebokitug — planned precision medicine-enabled RA trial · Trial initiationSEC filing ↗
Cash
Chart & Events
Core Clinical
Technology Summary
Scientific context
Detailed technology interpretation
Technology advantages
Clinical
Upcoming clinical milestones
Other pipelines
History / paused
Financial position
Upcoming milestones
Financial history
Annual trends
| Reported item | |||||
|---|---|---|---|---|---|
Reported shares and borrowings
Ownership and institutions
| Status | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|